Phelan K, Boccuto L, Rogers RC, Sarasua SM, McDermid HE (2015). "Letter to the editor regarding Disciglio et al.: interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome". Am J Med Genet A. 167 (7): 1679–80. doi:10.1002/ajmg.a.36788. PMID26295085. S2CID36651351.
Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, Phelan K, DuPont BR, Collins JS (2011-11-01). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". Journal of Medical Genetics. 48 (11): 761–766. doi:10.1136/jmedgenet-2011-100225. ISSN1468-6244. PMID21984749. S2CID28620399.
Hannachi H, Mougou S, Benabdallah I, Soayh N, Kahloul N, Gaddour N, Le Lorc'h M, Sanlaville D, El Ghezal H (2013-01-01). "Molecular and phenotypic characterization of ring chromosome 22 in two unrelated patients". Cytogenetic and Genome Research. 140 (1): 1–11. doi:10.1159/000350785. ISSN1424-859X. PMID23635516. S2CID25287674.
Cusmano-Ozog K, Manning MA, Hoyme HE (2007-11-15). "22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay". American Journal of Medical Genetics Part C. 145C (4): 393–398. doi:10.1002/ajmg.c.30155. ISSN1552-4876. PMID17926345. S2CID25733076.
Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS (2011-09-01). "Growth in Phelan-McDermid syndrome". American Journal of Medical Genetics Part A. 155A (9): 2324–2326. doi:10.1002/ajmg.a.34158. ISSN1552-4833. PMID21834045. S2CID20565974.
Sarasua SM, et al. (2011). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". J Med Genet. 48 (11): 761–6. doi:10.1136/jmedgenet-2011-100225. PMID21984749. S2CID28620399.
Simenson K, et al. (2013). "A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region". Am J Med Genet A. 164A (3): 806–9. doi:10.1002/ajmg.a.36358. PMID24375995. S2CID7917552.
Disciglio V, et al. (2014). "Interstitial 22q13 Deletions Not Involving SHANK3 Gene: A New Contiguous Gene Syndrome". Am J Med Genet A. 164 (7): 1666–76. doi:10.1002/ajmg.a.36513. PMID24700646. S2CID205318899.
Schaefer GB, Mendelsohn NJ, Committee for the Professional Practice and Guidelines (2013-05-01). "Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions". Genetics in Medicine. 15 (5): 399–407. doi:10.1038/gim.2013.32. ISSN1098-3600. PMID23519317. S2CID2374142.
Kirkpatrick BE, El-Khechen D (2011-01-01). "A unique presentation of 22q13 deletion syndrome: multicystic kidney, orofacial clefting, and Wilms' tumor". Clinical Dysmorphology. 20 (1): 53–54. doi:10.1097/MCD.0b013e32833effb1. ISSN1473-5717. PMID20827177.
Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J (2005-08-30). "Molecular and phenotypic characterization of ring chromosome 22". American Journal of Medical Genetics Part A. 137 (2): 139–147. doi:10.1002/ajmg.a.30780. ISSN1552-4825. PMID16059935. S2CID21211829.
Phelan K, Boccuto L, Rogers RC, Sarasua SM, McDermid HE (2015). "Letter to the editor regarding Disciglio et al.: interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome". Am J Med Genet A. 167 (7): 1679–80. doi:10.1002/ajmg.a.36788. PMID26295085. S2CID36651351.
Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, Phelan K, DuPont BR, Collins JS (2011-11-01). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". Journal of Medical Genetics. 48 (11): 761–766. doi:10.1136/jmedgenet-2011-100225. ISSN1468-6244. PMID21984749. S2CID28620399.
Hannachi H, Mougou S, Benabdallah I, Soayh N, Kahloul N, Gaddour N, Le Lorc'h M, Sanlaville D, El Ghezal H (2013-01-01). "Molecular and phenotypic characterization of ring chromosome 22 in two unrelated patients". Cytogenetic and Genome Research. 140 (1): 1–11. doi:10.1159/000350785. ISSN1424-859X. PMID23635516. S2CID25287674.
Cusmano-Ozog K, Manning MA, Hoyme HE (2007-11-15). "22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay". American Journal of Medical Genetics Part C. 145C (4): 393–398. doi:10.1002/ajmg.c.30155. ISSN1552-4876. PMID17926345. S2CID25733076.
Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS (2011-09-01). "Growth in Phelan-McDermid syndrome". American Journal of Medical Genetics Part A. 155A (9): 2324–2326. doi:10.1002/ajmg.a.34158. ISSN1552-4833. PMID21834045. S2CID20565974.
Sarasua SM, et al. (2011). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". J Med Genet. 48 (11): 761–6. doi:10.1136/jmedgenet-2011-100225. PMID21984749. S2CID28620399.
Simenson K, et al. (2013). "A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region". Am J Med Genet A. 164A (3): 806–9. doi:10.1002/ajmg.a.36358. PMID24375995. S2CID7917552.
Disciglio V, et al. (2014). "Interstitial 22q13 Deletions Not Involving SHANK3 Gene: A New Contiguous Gene Syndrome". Am J Med Genet A. 164 (7): 1666–76. doi:10.1002/ajmg.a.36513. PMID24700646. S2CID205318899.
Schaefer GB, Mendelsohn NJ, Committee for the Professional Practice and Guidelines (2013-05-01). "Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions". Genetics in Medicine. 15 (5): 399–407. doi:10.1038/gim.2013.32. ISSN1098-3600. PMID23519317. S2CID2374142.
Kirkpatrick BE, El-Khechen D (2011-01-01). "A unique presentation of 22q13 deletion syndrome: multicystic kidney, orofacial clefting, and Wilms' tumor". Clinical Dysmorphology. 20 (1): 53–54. doi:10.1097/MCD.0b013e32833effb1. ISSN1473-5717. PMID20827177.
Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J (2005-08-30). "Molecular and phenotypic characterization of ring chromosome 22". American Journal of Medical Genetics Part A. 137 (2): 139–147. doi:10.1002/ajmg.a.30780. ISSN1552-4825. PMID16059935. S2CID21211829.
Phelan K, Boccuto L, Rogers RC, Sarasua SM, McDermid HE (2015). "Letter to the editor regarding Disciglio et al.: interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome". Am J Med Genet A. 167 (7): 1679–80. doi:10.1002/ajmg.a.36788. PMID26295085. S2CID36651351.
Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, Phelan K, DuPont BR, Collins JS (2011-11-01). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". Journal of Medical Genetics. 48 (11): 761–766. doi:10.1136/jmedgenet-2011-100225. ISSN1468-6244. PMID21984749. S2CID28620399.
Hannachi H, Mougou S, Benabdallah I, Soayh N, Kahloul N, Gaddour N, Le Lorc'h M, Sanlaville D, El Ghezal H (2013-01-01). "Molecular and phenotypic characterization of ring chromosome 22 in two unrelated patients". Cytogenetic and Genome Research. 140 (1): 1–11. doi:10.1159/000350785. ISSN1424-859X. PMID23635516. S2CID25287674.
Cusmano-Ozog K, Manning MA, Hoyme HE (2007-11-15). "22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay". American Journal of Medical Genetics Part C. 145C (4): 393–398. doi:10.1002/ajmg.c.30155. ISSN1552-4876. PMID17926345. S2CID25733076.
Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS (2011-09-01). "Growth in Phelan-McDermid syndrome". American Journal of Medical Genetics Part A. 155A (9): 2324–2326. doi:10.1002/ajmg.a.34158. ISSN1552-4833. PMID21834045. S2CID20565974.
Sarasua SM, et al. (2011). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". J Med Genet. 48 (11): 761–6. doi:10.1136/jmedgenet-2011-100225. PMID21984749. S2CID28620399.
Simenson K, et al. (2013). "A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region". Am J Med Genet A. 164A (3): 806–9. doi:10.1002/ajmg.a.36358. PMID24375995. S2CID7917552.
Disciglio V, et al. (2014). "Interstitial 22q13 Deletions Not Involving SHANK3 Gene: A New Contiguous Gene Syndrome". Am J Med Genet A. 164 (7): 1666–76. doi:10.1002/ajmg.a.36513. PMID24700646. S2CID205318899.
Schaefer GB, Mendelsohn NJ, Committee for the Professional Practice and Guidelines (2013-05-01). "Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions". Genetics in Medicine. 15 (5): 399–407. doi:10.1038/gim.2013.32. ISSN1098-3600. PMID23519317. S2CID2374142.
Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J (2005-08-30). "Molecular and phenotypic characterization of ring chromosome 22". American Journal of Medical Genetics Part A. 137 (2): 139–147. doi:10.1002/ajmg.a.30780. ISSN1552-4825. PMID16059935. S2CID21211829.
Anderlid BM, Schoumans J, Annerén G, Tapia-Paez I, Dumanski J, Blennow E, Nordenskjöld M (2002-05-01). "FISH-mapping of a 100-kb terminal 22q13 deletion". Human Genetics. 110 (5): 439–443. doi:10.1007/s00439-002-0713-7. ISSN0340-6717. PMID12073014. S2CID6018914.
Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, Phelan K, DuPont BR, Collins JS (2011-11-01). "Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)". Journal of Medical Genetics. 48 (11): 761–766. doi:10.1136/jmedgenet-2011-100225. ISSN1468-6244. PMID21984749. S2CID28620399.
Hannachi H, Mougou S, Benabdallah I, Soayh N, Kahloul N, Gaddour N, Le Lorc'h M, Sanlaville D, El Ghezal H (2013-01-01). "Molecular and phenotypic characterization of ring chromosome 22 in two unrelated patients". Cytogenetic and Genome Research. 140 (1): 1–11. doi:10.1159/000350785. ISSN1424-859X. PMID23635516. S2CID25287674.
Cusmano-Ozog K, Manning MA, Hoyme HE (2007-11-15). "22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay". American Journal of Medical Genetics Part C. 145C (4): 393–398. doi:10.1002/ajmg.c.30155. ISSN1552-4876. PMID17926345. S2CID25733076.
Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS (2011-09-01). "Growth in Phelan-McDermid syndrome". American Journal of Medical Genetics Part A. 155A (9): 2324–2326. doi:10.1002/ajmg.a.34158. ISSN1552-4833. PMID21834045. S2CID20565974.
Schaefer GB, Mendelsohn NJ, Committee for the Professional Practice and Guidelines (2013-05-01). "Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions". Genetics in Medicine. 15 (5): 399–407. doi:10.1038/gim.2013.32. ISSN1098-3600. PMID23519317. S2CID2374142.
Kirkpatrick BE, El-Khechen D (2011-01-01). "A unique presentation of 22q13 deletion syndrome: multicystic kidney, orofacial clefting, and Wilms' tumor". Clinical Dysmorphology. 20 (1): 53–54. doi:10.1097/MCD.0b013e32833effb1. ISSN1473-5717. PMID20827177.
Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J (2005-08-30). "Molecular and phenotypic characterization of ring chromosome 22". American Journal of Medical Genetics Part A. 137 (2): 139–147. doi:10.1002/ajmg.a.30780. ISSN1552-4825. PMID16059935. S2CID21211829.